The researchers around Lianfeng ZHANG used the CRISPR/Cas9 system for genome editing, resulting in animals with clinical symptoms – severe coagulopathy – typical for this disease.
CAS news release, February 11, 2014
The researchers around Lianfeng ZHANG used the CRISPR/Cas9 system for genome editing, resulting in animals with clinical symptoms – severe coagulopathy – typical for this disease.
CAS news release, February 11, 2014